TY - JOUR
T1 - Hemostasis, inflammation, and fatal and nonfatal coronary heart disease
T2 - Long-term follow-up of the atherosclerosis risk in communities (ARIC) cohort
AU - Kucharska-Newton, Anna M.
AU - Couper, David J.
AU - Pankow, James S.
AU - Prineas, Ronald J.
AU - Rea, Thomas D.
AU - Sotoodehnia, Nona
AU - Chakravarti, Aravinda
AU - Folsom, Aaron R.
AU - Siscovick, David S.
AU - Rosamond, Wayne D.
PY - 2009/12
Y1 - 2009/12
N2 - OBJECTIVE-: This study examines the hypothesis that chronic inflammation is associated with a higher risk of cardiac death compared to the risk of nonfatal myocardial infarction. METHODS AND RESULTS-: Cardiac death and nonfatal MI events were identified in the ARIC cohort during follow-up from 1987 through 2001. Markers of inflammation and hemostasis were determined at baseline using standardized procedures. Cox proportional hazard regression and polytomous logistic regression were used to estimate associations. We observed a positive gradient in incidence of sudden cardiac death (SCD), nonsudden cardiac death (NSCD), and nonfatal MI in association with decreasing levels of albumin and increasing levels of white blood cell count and of markers of hemostasis (fibrinogen, von Willebrand factor, factor VIIIc). Associations for von Willebrand factor were stronger for fatal relative to nonfatal events (3rd versus 1st tertile hazard ratios: SCD 3.11 [95% CI 2.10, 4.59], NSCD 2.12 [95% CI 1.28, 3.49], nonfatal MI 1.42 [95% CI 1.19, 1.70]). For factor VIIIc those associations were strongest for sudden cardiac death: SCD 3.16 (95% CI 2.18, 4.58), NSCD 1.44 (95% CI 0.93, 2.24), nonfatal MI 1.54 (95% CI 1.29, 1.84). Gradients of association for fibrinogen and white blood cell count, examined over tertiles of distribution and per one SD increase, were similar for the 3 end points. All associations were independent of smoking status. CONCLUSION-: von Willebrand factor and factor VIIIc are associated with an increased risk of cardiac death as compared to the risk of nonfatal MI.
AB - OBJECTIVE-: This study examines the hypothesis that chronic inflammation is associated with a higher risk of cardiac death compared to the risk of nonfatal myocardial infarction. METHODS AND RESULTS-: Cardiac death and nonfatal MI events were identified in the ARIC cohort during follow-up from 1987 through 2001. Markers of inflammation and hemostasis were determined at baseline using standardized procedures. Cox proportional hazard regression and polytomous logistic regression were used to estimate associations. We observed a positive gradient in incidence of sudden cardiac death (SCD), nonsudden cardiac death (NSCD), and nonfatal MI in association with decreasing levels of albumin and increasing levels of white blood cell count and of markers of hemostasis (fibrinogen, von Willebrand factor, factor VIIIc). Associations for von Willebrand factor were stronger for fatal relative to nonfatal events (3rd versus 1st tertile hazard ratios: SCD 3.11 [95% CI 2.10, 4.59], NSCD 2.12 [95% CI 1.28, 3.49], nonfatal MI 1.42 [95% CI 1.19, 1.70]). For factor VIIIc those associations were strongest for sudden cardiac death: SCD 3.16 (95% CI 2.18, 4.58), NSCD 1.44 (95% CI 0.93, 2.24), nonfatal MI 1.54 (95% CI 1.29, 1.84). Gradients of association for fibrinogen and white blood cell count, examined over tertiles of distribution and per one SD increase, were similar for the 3 end points. All associations were independent of smoking status. CONCLUSION-: von Willebrand factor and factor VIIIc are associated with an increased risk of cardiac death as compared to the risk of nonfatal MI.
KW - Hemostasis
KW - Inflammation
KW - Nonfatal myocardial infarction
KW - Sudden cardiac death
KW - Von Willebrand factor
UR - http://www.scopus.com/inward/record.url?scp=73849124227&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=73849124227&partnerID=8YFLogxK
U2 - 10.1161/ATVBAHA.109.192740
DO - 10.1161/ATVBAHA.109.192740
M3 - Article
C2 - 19797708
AN - SCOPUS:73849124227
SN - 1079-5642
VL - 29
SP - 2182
EP - 2190
JO - Arteriosclerosis, thrombosis, and vascular biology
JF - Arteriosclerosis, thrombosis, and vascular biology
IS - 12
ER -